Daiwa Securities Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-90
Closed -$1K 1204
2025
Q4
$1K Hold
90
﹤0.01% 1337
2025
Q3
$2K Hold
90
﹤0.01% 1258
2025
Q2
$1K Hold
90
﹤0.01% 1246
2025
Q1
$1K Hold
90
﹤0.01% 1212
2024
Q4
$2K Hold
90
﹤0.01% 1210
2024
Q3
$2K Hold
90
﹤0.01% 1212
2024
Q2
$2K Hold
90
﹤0.01% 1242
2024
Q1
$3K Hold
90
﹤0.01% 1231
2023
Q4
$3K Hold
90
﹤0.01% 1238
2023
Q3
$2K Hold
90
﹤0.01% 1211
2023
Q2
$3K Sell
90
-4,019
-98% -$109K ﹤0.01% 1212
2023
Q1
$98K Buy
4,109
+789
+24% +$14.2K ﹤0.01% 995
2022
Q4
$56K Sell
3,320
-1,540
-32% -$26.9K ﹤0.01% 1023
2022
Q3
$72K Sell
4,860
-1,044
-18% -$17.5K ﹤0.01% 1031
2022
Q2
$93K Buy
5,904
+2,401
+69% +$47.1K ﹤0.01% 1031
2022
Q1
$94K Buy
3,503
+1,071
+44% +$27.3K ﹤0.01% 1048
2021
Q4
$90K Buy
2,432
+322
+15% +$13.1K ﹤0.01% 1022
2021
Q3
$101K Buy
2,110
+2,064
+4,487% +$92.5K ﹤0.01% 993
2021
Q2
$2K Hold
46
﹤0.01% 1134
2021
Q1
$2K Hold
46
﹤0.01% 1135
2020
Q4
$2K Buy
+46
New +$3.12K ﹤0.01% 1111

Other funds holding ARCT